- Home
- EPRX vs ZOM Comparison
EPRX vs ZOM Comparison
Compare EPRX & ZOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- ZOM
- Stock Information
- Founded
- EPRX 2011
- ZOM 2015
- Country
- EPRX Canada
- ZOM United States
- Employees
- EPRX N/A
- ZOM N/A
- Industry
- EPRX
- ZOM Biotechnology: Pharmaceutical Preparations
- Sector
- EPRX
- ZOM Health Care
- Exchange
- EPRX NYSE
- ZOM Nasdaq
- Market Cap
- EPRX 109.7M
- ZOM 128.4M
- IPO Year
- EPRX N/A
- ZOM N/A
- Fundamental
- Price
- EPRX $3.20
- ZOM $0.13
- Analyst Decision
- EPRX Strong Buy
- ZOM
- Analyst Count
- EPRX 1
- ZOM 0
- Target Price
- EPRX $9.00
- ZOM N/A
- AVG Volume (30 Days)
- EPRX 6.9K
- ZOM 8.2M
- Earning Date
- EPRX 02-07-2025
- ZOM 11-07-2024
- Dividend Yield
- EPRX N/A
- ZOM N/A
- EPS Growth
- EPRX N/A
- ZOM N/A
- EPS
- EPRX N/A
- ZOM N/A
- Revenue
- EPRX N/A
- ZOM $26,727,000.00
- Revenue This Year
- EPRX N/A
- ZOM $10.28
- Revenue Next Year
- EPRX N/A
- ZOM $28.00
- P/E Ratio
- EPRX N/A
- ZOM N/A
- Revenue Growth
- EPRX N/A
- ZOM 11.33
- 52 Week Low
- EPRX $2.20
- ZOM $0.12
- 52 Week High
- EPRX $4.08
- ZOM $0.20
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- ZOM 50.93
- Support Level
- EPRX N/A
- ZOM $0.13
- Resistance Level
- EPRX N/A
- ZOM $0.16
- Average True Range (ATR)
- EPRX 0.00
- ZOM 0.01
- MACD
- EPRX 0.00
- ZOM -0.00
- Stochastic Oscillator
- EPRX 0.00
- ZOM 27.44
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.